Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1247

β-Lactoglobulin produced by Kluyveromyces lactis CCTCC M20241460

Intended Use: Intended for use as a source of protein at levels ranging from 5 to 35% in meal replacements and supplements, powdered nutritional beverages, electrolyte-type sports drinks, high protein performance nutritional beverages nutritional bars, milk, milk drinks and drink mixes, milk substitutes, cream and cream substitutes, half & half, cream cheese, cheese spread, whipped cream, spreads and dips, yogurt and fermented milk products, cheese used as an ingredient, semi-hard cheese, ice cream and frozen yogurt, desserts and mousses, confections, coatings and fillings, cookies, brownies, crackers, popcorn, potato chips, tortilla chips, hard pretzels/snack mix, doughnuts, toaster pastries, muffins, French toast, crepes, pancakes, bagels, scones, biscuits, croissants, breads and rolls, English muffins, pizza crust, creamy salad dressings, sauces, and egg substitutes.
Basis: Scientific procedures
Notifier: Shanghai Changing Biotechnology Co., Ltd.
Notifier Address: 3rd Floor, Building 4, No.789/799/855, Zi Ping Road
Pudong District, Shanghai, 201318
CHINA
GRAS Notice (releasable information): GRN 1247 (in PDF) (10.9 MB)
Date of closure: Sep 19, 2025
FDA's Letter: FDA has no questions (209 kB)
-
-